<p>a. median (IQR) pVL up to 48 weeks after ART stop. b. predicted pVL over 4–48 weeks after ART stop, based on a representative participant (male infected through sex with men, aged 40 years and with CD4 count 600 cells/mm<sup>3</sup> at ART stop; values in brackets are the 95% CI). CI = confidence intervals, IQR = interquartile range, pLV = plasma viral load.</p
Introduction: Data on patients with long-term exposure to ART is scarce because controlled studies u...
#<p>, cells/µl;</p>&<p>, HIV RNA copies per ml plasma (log<sub>10</sub>);</p>*<p>, months; ART, anti...
<p>(A) CD4∶CD8 ratio in ART-suppressed Individuals at three timepoints (pre-ART, first timepoint on ...
<p>a. median (IQR) pVL up to 48 weeks after ART stop. b. predicted pVL over 4–48 weeks after ART sto...
The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
OBJECTIVES: The magnitude of HIV viral rebound following ART cessation has consequences for clinical...
<div><p>Objective</p><p>A minority of HIV-1 positive individuals treated with antiretroviral therapy...
OBJECTIVE:A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in prim...
OBJECTIVE: A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in pri...
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
Background: Early ART initiation is associated with impact on HIV-1 reservoir establishment and deca...
OBJECTIVE: To investigate the effect of a short course of HAART during primary HIV infection (PHI) o...
ObjectiveDespite evidence supporting antiretroviral therapy (ART) in recent HIV infection, little is...
Introduction: Data on patients with long-term exposure to ART is scarce because controlled studies u...
#<p>, cells/µl;</p>&<p>, HIV RNA copies per ml plasma (log<sub>10</sub>);</p>*<p>, months; ART, anti...
<p>(A) CD4∶CD8 ratio in ART-suppressed Individuals at three timepoints (pre-ART, first timepoint on ...
<p>a. median (IQR) pVL up to 48 weeks after ART stop. b. predicted pVL over 4–48 weeks after ART sto...
The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
OBJECTIVES: The magnitude of HIV viral rebound following ART cessation has consequences for clinical...
<div><p>Objective</p><p>A minority of HIV-1 positive individuals treated with antiretroviral therapy...
OBJECTIVE:A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in prim...
OBJECTIVE: A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in pri...
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
Background: Early ART initiation is associated with impact on HIV-1 reservoir establishment and deca...
OBJECTIVE: To investigate the effect of a short course of HAART during primary HIV infection (PHI) o...
ObjectiveDespite evidence supporting antiretroviral therapy (ART) in recent HIV infection, little is...
Introduction: Data on patients with long-term exposure to ART is scarce because controlled studies u...
#<p>, cells/µl;</p>&<p>, HIV RNA copies per ml plasma (log<sub>10</sub>);</p>*<p>, months; ART, anti...
<p>(A) CD4∶CD8 ratio in ART-suppressed Individuals at three timepoints (pre-ART, first timepoint on ...